Blood biopsy test reads platelets to detect human lung cancer
Monday, August 14, 2017 - 13:52
in Health & Medicine
Researchers have designed a different approach to the liquid biopsy. Rather than looking for evidence of cancer DNA or other biomarkers in the blood, their test (called thromboSeq) could diagnose non-small cell lung cancer with close to 90 percent accuracy by detecting tumor RNA absorbed by circulating platelets, also known as thrombocytes. Non-small cell lung cancers make up the majority of lung cancer cases.